PROP1 Gene Pituitary Hormone Deficiency Type 2 Genetic Test
At DNA Labs UAE, we offer the PROP1 Gene Pituitary Hormone Deficiency Type 2 Genetic Test for individuals who suspect they may have this condition. This test is designed to analyze and identify mutations or variations in the PROP1 gene, which is responsible for producing a protein crucial for the development and function of the pituitary gland.
Test Details
The PROP1 gene is responsible for producing a protein that plays a crucial role in the development and function of the pituitary gland. Mutations in this gene can lead to a condition called pituitary hormone deficiency type 2 (PHD2), also known as combined pituitary hormone deficiency (CPHD) type 2. Our Next-Generation Sequencing (NGS) genetic testing method allows us to analyze and identify genetic variations or mutations in an individual’s DNA.
Components and Price
The cost of the PROP1 Gene Pituitary Hormone Deficiency Type 2 Genetic Test is AED 4400.0. The test requires a blood sample, extracted DNA, or one drop of blood on an FTA Card.
Report Delivery
The report for the PROP1 Gene Pituitary Hormone Deficiency Type 2 Genetic Test will be delivered within 3 to 4 weeks.
Test Type and Doctor
The test type for this genetic test is Dysmorphology, which focuses on the study of abnormal physical features or development. The test is typically recommended by pediatricians who specialize in genetics.
Test Department
The PROP1 Gene Pituitary Hormone Deficiency Type 2 Genetic Test is conducted in our Genetics department.
Pre Test Information
Prior to undergoing the PROP1 Gene Pituitary Hormone Deficiency Type 2 NGS Genetic DNA Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session may be conducted to draw a pedigree chart of family members affected by the PROP1 Gene Pituitary Hormone Deficiency Type 2 NGS Genetic DNA Test gene PROP1.
Conclusion
The PROP1 Gene Pituitary Hormone Deficiency Type 2 NGS Genetic Test is a specialized genetic test that focuses on identifying mutations in the PROP1 gene associated with PHD2. This test provides valuable information for the diagnosis, treatment, and family planning of individuals with this condition. By undergoing this test, individuals can gain important insights into their genetic makeup and make informed decisions about their healthcare.
Test Name | PROP1 Gene Pituitary hormone deficiency type 2 Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Dysmorphology |
Doctor | Pediatrics |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for PROP1 Gene Pituitary hormone deficiency type 2 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with PROP1 Gene Pituitary hormone deficiency type 2 NGS Genetic DNA Test gene PROP1 |
Test Details |
The PROP1 gene is responsible for producing a protein that plays a crucial role in the development and function of the pituitary gland. Mutations in this gene can lead to a condition called pituitary hormone deficiency type 2 (PHD2), also known as combined pituitary hormone deficiency (CPHD) type 2. NGS (Next-Generation Sequencing) genetic testing is a powerful tool used to analyze and identify genetic variations or mutations in an individual’s DNA. In the context of PHD2, NGS genetic testing can be used to sequence the PROP1 gene and identify any mutations or variations that may be present. By identifying specific mutations in the PROP1 gene, NGS genetic testing can help diagnose individuals with PHD2 and provide important information for their medical management. It can also be used for genetic counseling and family planning purposes. Overall, the PROP1 gene pituitary hormone deficiency type 2 NGS genetic test is a specialized genetic test that focuses on identifying mutations in the PROP1 gene associated with PHD2, providing valuable information for diagnosis, treatment, and family planning. |